Tr1X Inc. (pr. \Trix\) is a biotechnology company dedicated to the development of novel cellular immunotherapies for patients with autoimmune and inflammatory diseases. The Company uses its proprietary platform for the generation of first-in-class cell therapy products aimed at rebalancing the immune system and restoring homeostasis, leading to long term tolerance. Tr1X is headquartered in La Jolla, CA.
Tr1X Address
San Diego, CA United States
Tr1X Email
Past Companies
Appia BioSr Director Research
Atara BiotherapeuticsHead of CAR-T Preclinical Research
Immatics BiotechnologiesDirector - Allogeneic Platform Development